Newsroom

Sorted by: Latest

-

ABIONYX Pharma fait le point sur son activité et sa position de trésorerie du 1er trimestre 2026

TOULOUSE, France & FULLERTON, Calif.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société biopharmaceutique de nouvelle génération qui développe des thérapies innovantes dans le sepsis et les soins intensifs, fondées sur une plateforme technologique exclusive basée sur l’apoA-I, fait le point aujourd’hui sur son activité et la trésorerie et les équivalents de trésorerie au 31 mars 2026. ABIONYX Pharma a enregistré un chiffre d’affaires consolidé d...
-

ABIONYX Pharma Provides an Update on Its Operations and Cash Position for the First Quarter of 2026

TOULOUSE, France & FULLERTON, Calif.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – PEA PME eligible), a next-generation biopharmaceutical company developing innovative therapies for sepsis and critical care based on a proprietary apoA-I technology platform, today provides an update on its business and cash and cash equivalents as of March 31, 2026. ABIONYX Pharma recorded consolidated revenue of €0.8 million for the first quarter of 2026, a slight decrease compared t...
-

Samsara Sweeps Fleet Technology Rankings With 23 No. 1 Rankings Across Reports

SAN FRANCISCO--(BUSINESS WIRE)--Samsara Inc. ("Samsara") (NYSE: IOT), the pioneer of the Connected Operations® Platform, today announced it has earned the No. 1 spot on 23 separate Summer 2026 Grid Reports® on G2, the world's largest and most trusted software marketplace, more than any other fleet technology brand. Rankings are driven by verified customer reviews and reflect broad preference for the Samsara platform. “Seven consecutive quarters at No. 1 isn’t just a streak—it’s a signal,” said...
-

Cadence and Samsung Foundry Deepen 2nm and 3D‑IC Collaboration to Meet Surging AI Infrastructure and Physical AI Demand

SAN JOSE, Calif. & SEOUL, South Korea--(BUSINESS WIRE)--Cadence (Nasdaq: CDNS) and Samsung Foundry today announced development of a full portfolio of Memory and Interface IP, and expanded certification of Cadence’s agentic AI digital, custom, 3D‑IC and system design and analysis (SDA) flows for Samsung Foundry’s second-generation 2nm process technology. This collaboration delivers a signoff‑ready platform for next‑generation AI infrastructure and physical AI designs across data center, edge and...
-

Unilever Investing $270M in Global Innovation Center in New Haven, Connecticut

NEW HAVEN, Conn.--(BUSINESS WIRE)--Unilever today unveiled plans to develop a new Global Innovation Center in New Haven, Connecticut, opening by spring 2029. The center will be a leading hub for the company’s research and development for its personal care, beauty and wellbeing businesses in the U.S. and globally. The center further propels Unilever’s growth strategy in the U.S. market, raising the bar for research and development in the consumer goods industry and powering the company’s portfol...
-

DeVry University Earns Top 12 National Ranking in Spring 2026 National Cyber League Competition

LISLE, Ill.--(BUSINESS WIRE)--DeVry University Earns Top 12 National Ranking in Spring 2026 National Cyber League Competition...
-

DTLA Law Group Continues Expansion and Operations From Downtown Los Angeles Headquarters

LOS ANGELES--(BUSINESS WIRE)--DTLA Law Group continues to strengthen its presence in Downtown Los Angeles as the firm advances operations from its headquarters at 540 S. Santa Fe Avenue in the city’s Arts District. The 52,000-square-foot headquarters, which opened last year following an extensive renovation of the former Lucky Brand building, reflects the firm’s continued growth, expanding legal team and long-term investment in serving clients throughout California. “This space was designed to...
-

AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine

SEATTLE--(BUSINESS WIRE)--The Access to Advanced Health Institute (AAHI), a nonprofit biotech organization dedicated to developing vaccines and technologies for global health, today congratulates Eli Lilly and Company and Curevo Vaccine on Lilly’s acquisition of Curevo. Curevo’s lead asset, amezosvatein (CRV-101), is a Phase 3-ready subunit vaccine for the prevention of shingles (herpes zoster) that incorporates AAHI’s proprietary SLA-SE adjuvant. The acquisition underscores the growing recogni...
-

Securities Fraud Investigation Into AeroVironment, Inc. (AVAV) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AEROVIRONMENT, INC. (AVAV), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happe...
-

Graco Foundation Marks Company’s Centennial with $1 Million Commitment to Minnesota Nonprofits

MINNEAPOLIS--(BUSINESS WIRE)--In celebration of Graco’s 100th anniversary, the Graco Foundation announced a $1 million Centennial Impact Initiative to support 10 Minnesota nonprofit organizations advancing self-sufficiency, stability and workforce development, including technical training and career pathways aligned with Minnesota’s manufacturing and industrial workforce needs. Through the initiative, each nonprofit partner will receive a $100,000 grant to commemorate Graco’s centennial anniver...